Clinipace (dMed Clinical Research)

dMed Clinical Research is a global clinical research organization (CRO) providing comprehensive clinical trial management and drug development services for pharmaceutical, biotechnology, and medical technology companies. The company expanded its global presence through the acquisition of Clinipace, a technology-enabled CRO known for innovative clinical research solutions.

Founded originally as Clinipace in 2003 and headquartered in Morrisville, North Carolina, United States, the organization specializes in technology-driven clinical development services, helping sponsors conduct efficient and patient-focused clinical trials worldwide.

dMed Clinical Research provides services including Phase I–IV clinical trial management, clinical operations, regulatory affairs, clinical data management, biostatistics, medical writing, pharmacovigilance, and decentralized clinical trial solutions. The company supports studies across therapeutic areas including oncology, rare diseases, immunology, neuroscience, and advanced therapies.

The organization combines clinical expertise with digital technologies to improve trial efficiency, patient engagement, and data quality. Its solutions support global research programs by connecting sponsors, investigators, patients, and clinical sites through integrated platforms.

dMed Clinical Research follows international clinical research standards, including Good Clinical Practice (GCP), ICH guidelines, FDA requirements, EMA regulations, and quality management systems.

With global operations across North America, Europe, and Asia-Pacific, dMed Clinical Research supports healthcare innovators in accelerating the development of new therapies while maintaining scientific integrity and regulatory compliance.